A Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability of TAK-788 Followed by Evaluation of the Effects of a Low-Fat Meal on TAK-788 PK and Evaluation of Relative Bioavailability of TAK-788 Capsules in Healthy Participants
Clinical trial NCT03482453 · COMPLETED
Trial details
- NCT number
- NCT03482453
- Sponsor
- Millennium Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-28
- Primary completion
- 2018-12-22
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.